262 related articles for article (PubMed ID: 20091020)
1. Predictive power of screening for antibodies against insulinoma-associated protein 2 beta (IA-2beta) and zinc transporter-8 to select first-degree relatives of type 1 diabetic patients with risk of rapid progression to clinical onset of the disease: implications for prevention trials.
De Grijse J; Asanghanwa M; Nouthe B; Albrecher N; Goubert P; Vermeulen I; Van Der Meeren S; Decochez K; Weets I; Keymeulen B; Lampasona V; Wenzlau J; Hutton JC; Pipeleers D; Gorus FK;
Diabetologia; 2010 Mar; 53(3):517-24. PubMed ID: 20091020
[TBL] [Abstract][Full Text] [Related]
2. Screening for insulinoma antigen 2 and zinc transporter 8 autoantibodies: a cost-effective and age-independent strategy to identify rapid progressors to clinical onset among relatives of type 1 diabetic patients.
Gorus FK; Balti EV; Vermeulen I; Demeester S; Van Dalem A; Costa O; Dorchy H; Tenoutasse S; Mouraux T; De Block C; Gillard P; Decochez K; Wenzlau JM; Hutton JC; Pipeleers DG; Weets I;
Clin Exp Immunol; 2013 Jan; 171(1):82-90. PubMed ID: 23199327
[TBL] [Abstract][Full Text] [Related]
3. Contribution of antibodies against IA-2β and zinc transporter 8 to classification of diabetes diagnosed under 40 years of age.
Vermeulen I; Weets I; Asanghanwa M; Ruige J; Van Gaal L; Mathieu C; Keymeulen B; Lampasona V; Wenzlau JM; Hutton JC; Pipeleers DG; Gorus FK;
Diabetes Care; 2011 Aug; 34(8):1760-5. PubMed ID: 21715527
[TBL] [Abstract][Full Text] [Related]
4. Twenty-Year Progression Rate to Clinical Onset According to Autoantibody Profile, Age, and
Gorus FK; Balti EV; Messaaoui A; Demeester S; Van Dalem A; Costa O; Dorchy H; Mathieu C; Van Gaal L; Keymeulen B; Pipeleers DG; Weets I;
Diabetes Care; 2017 Aug; 40(8):1065-1072. PubMed ID: 28701370
[TBL] [Abstract][Full Text] [Related]
5. The diagnostic value of zinc transporter 8 autoantibody (ZnT8A) for type 1 diabetes in Chinese.
Yang L; Luo S; Huang G; Peng J; Li X; Yan X; Lin J; Wenzlau JM; Davidson HW; Hutton JC; Zhou Z
Diabetes Metab Res Rev; 2010 Oct; 26(7):579-84. PubMed ID: 20842762
[TBL] [Abstract][Full Text] [Related]
6. Triple specificity of ZnT8 autoantibodies in relation to HLA and other islet autoantibodies in childhood and adolescent type 1 diabetes.
Andersson C; Vaziri-Sani F; Delli A; Lindblad B; Carlsson A; Forsander G; Ludvigsson J; Marcus C; Samuelsson U; Ivarsson S; Lernmark A; Larsson HE;
Pediatr Diabetes; 2013 Mar; 14(2):97-105. PubMed ID: 22957668
[TBL] [Abstract][Full Text] [Related]
7. Combined positivity for HLA DQ2/DQ8 and IA-2 antibodies defines population at high risk of developing type 1 diabetes.
Decochez K; Truyen I; van der Auwera B; Weets I; Vandemeulebroucke E; de Leeuw IH; Keymeulen B; Mathieu C; Rottiers R; Pipeleers DG; Gorus FK;
Diabetologia; 2005 Apr; 48(4):687-94. PubMed ID: 15756536
[TBL] [Abstract][Full Text] [Related]
8. HLA-A*24 is an independent predictor of 5-year progression to diabetes in autoantibody-positive first-degree relatives of type 1 diabetic patients.
Mbunwe E; Van der Auwera BJ; Vermeulen I; Demeester S; Van Dalem A; Balti EV; Van Aken S; Derdelinckx L; Dorchy H; De Schepper J; van Schravendijk C; Wenzlau JM; Hutton JC; Pipeleers D; Weets I; Gorus FK;
Diabetes; 2013 Apr; 62(4):1345-50. PubMed ID: 23160529
[TBL] [Abstract][Full Text] [Related]
9. Zinc transporter-8 autoantibodies improve prediction of type 1 diabetes in relatives positive for the standard biochemical autoantibodies.
Yu L; Boulware DC; Beam CA; Hutton JC; Wenzlau JM; Greenbaum CJ; Bingley PJ; Krischer JP; Sosenko JM; Skyler JS; Eisenbarth GS; Mahon JL;
Diabetes Care; 2012 Jun; 35(6):1213-8. PubMed ID: 22446173
[TBL] [Abstract][Full Text] [Related]
10. Characteristics of rapid vs slow progression to type 1 diabetes in multiple islet autoantibody-positive children.
Achenbach P; Hummel M; Thümer L; Boerschmann H; Höfelmann D; Ziegler AG
Diabetologia; 2013 Jul; 56(7):1615-22. PubMed ID: 23539116
[TBL] [Abstract][Full Text] [Related]
11. An important minority of prediabetic first-degree relatives of type 1 diabetic patients derives from seroconversion to persistent autoantibody positivity after 10 years of age.
Vermeulen I; Weets I; Costa O; Asanghanwa M; Verhaeghen K; Decochez K; Ruige J; Casteels K; Wenzlau J; Hutton JC; Pipeleers DG; Gorus FK;
Diabetologia; 2012 Feb; 55(2):413-20. PubMed ID: 22095238
[TBL] [Abstract][Full Text] [Related]
12. Only multiple autoantibodies to islet cells (ICA), insulin, GAD65, IA-2 and IA-2beta predict immune-mediated (Type 1) diabetes in relatives.
Maclaren N; Lan M; Coutant R; Schatz D; Silverstein J; Muir A; Clare-Salzer M; She JX; Malone J; Crockett S; Schwartz S; Quattrin T; DeSilva M; Vander Vegt P; Notkins A; Krischer J
J Autoimmun; 1999 Jun; 12(4):279-87. PubMed ID: 10330299
[TBL] [Abstract][Full Text] [Related]
13. Detection and characterization of ZnT8 autoantibodies could help to screen latent autoimmune diabetes in adult-onset patients with type 2 phenotype.
Trabucchi A; Faccinetti NI; Guerra LL; Puchulu FM; Frechtel GD; Poskus E; Valdez SN
Autoimmunity; 2012 Mar; 45(2):137-42. PubMed ID: 21875382
[TBL] [Abstract][Full Text] [Related]
14. The role of autoantibodies to zinc transporter 8 in prediction of type 1 diabetes in relatives: lessons from the European Nicotinamide Diabetes Intervention Trial (ENDIT) cohort.
Long AE; Gooneratne AT; Rokni S; Williams AJ; Bingley PJ
J Clin Endocrinol Metab; 2012 Feb; 97(2):632-7. PubMed ID: 22162482
[TBL] [Abstract][Full Text] [Related]
15. In antibody-positive first-degree relatives of patients with type 1 diabetes, HLA-A*24 and HLA-B*18, but not HLA-B*39, are predictors of impending diabetes with distinct HLA-DQ interactions.
Mbunwe E; Van der Auwera BJ; Weets I; Van Crombrugge P; Crenier L; Coeckelberghs M; Seret N; Decochez K; Vandemeulebroucke E; Gillard P; Keymeulen B; van Schravendijk C; Wenzlau JM; Hutton JC; Pipeleers DG; Gorus FK;
Diabetologia; 2013 Sep; 56(9):1964-70. PubMed ID: 23712485
[TBL] [Abstract][Full Text] [Related]
16. Autoantibodies and high-risk HLA susceptibility markers in first-degree relatives of Brazilian patients with type 1 diabetes mellitus: a progression to disease based study.
Alves LI; Davini E; Correia MR; Fukui RT; Santos RF; Cunha MR; Rocha DM; Volpini WM; Silva ME
J Clin Immunol; 2012 Aug; 32(4):778-85. PubMed ID: 22402866
[TBL] [Abstract][Full Text] [Related]
17. Distribution of autoantibodies to insulinoma-associated antigen-2 and zinc transporter 8 in type 1 diabetes and latent autoimmune diabetes: A nationwide, multicentre, cross-sectional study.
Fan W; Nan X; Peng Y; Li X; Xiang Y; Yan X; Xie Z; Zhou H; Tang X; Cheng J; Niu X; Liu J; Ji Q; Ji L; Huang G; Zhou Z
Diabetes Metab Res Rev; 2023 Feb; 39(2):e3592. PubMed ID: 36401613
[TBL] [Abstract][Full Text] [Related]
18. High frequency of diabetes-specific autoantibodies in parents of children with type 1 diabetes. DENIS study group.
Seissler J; Atik Y; Klinghammer A; Scherbaum WA
Horm Metab Res; 1999 Dec; 31(12):657-61. PubMed ID: 10668918
[TBL] [Abstract][Full Text] [Related]
19. Humoral responses to islet antigen-2 and zinc transporter 8 are attenuated in patients carrying HLA-A*24 alleles at the onset of type 1 diabetes.
Long AE; Gillespie KM; Aitken RJ; Goode JC; Bingley PJ; Williams AJ
Diabetes; 2013 Jun; 62(6):2067-71. PubMed ID: 23396399
[TBL] [Abstract][Full Text] [Related]
20. Positive autoantibodies to ZnT8 indicate elevated risk for additional autoimmune conditions in patients with Addison's disease.
Fichna M; Rogowicz-Frontczak A; Żurawek M; Fichna P; Gryczyńska M; Zozulińska-Ziółkiewicz D; Ruchała M
Endocrine; 2016 Jul; 53(1):249-57. PubMed ID: 26972575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
